Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test

European Journal of Pharmacology

Volumn 557, Issue 1, 2007, Pages 32-36

  Chen, Xiaohong ^a   Geller, Ellen B ^a   Adler, Martin W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

(Rats); Antinociception; Cold water tail flick test; Nociceptin orphanin FQ; Opioid agonists

Indexed keywords

DELTA OPIATE RECEPTOR AGONIST; DYNORPHIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR AGONIST; MORPHICEPTIN[3 (N METHYLPHENYLALANINE) 4 DEXTRO PROLINAMIDE]; MORPHINE; MU OPIATE RECEPTOR AGONIST; NOCICEPTIN; SODIUM CHLORIDE; SPIRADOLINE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; COLD WATER TAIL FLICK TEST; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; COLD; DYNORPHINS; ENDORPHINS; ENKEPHALIN, D-PENICILLAMINE (2,5)-; MALE; MORPHINE; OPIOID PEPTIDES; PAIN; PAIN MEASUREMENT; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; TAIL; WATER;

EID: 33846385772     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.001     Document Type: Article

References (42)

1. Bytner B., Huang Y.H., Yu L.C., Lundeberg T., Nylander I., and Rosen A. Nociceptin/orphanin FQ into the rat periaqueductal gray decreases the withdrawal latency to heat and loading, an effect reversed by (Nphe(1))nociceptin(1-13)NH(2). Brain Res. 922 (2001) 118-124
2. Chang K.J., Wei E.T., Killian A., and Chang J.K. Potent morphiceptin analogs: structure activity relationships and morphine-like activities. J. Pharmacol. Exp. Ther. 227 (1983) 403-408
3. Chavkin C., James I.F., and Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 215 (1982) 413-415
4. Chen X., McClatchy D.B., Geller E.B., Liu-Chen L., Tallarida R.J., and Adler M.W. Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociception. Brain Res. 904 (2001) 252-258
5. Citterio F., Corradini L., Smith R.D., and Bertorelli R. Nociceptin attenuates opioid and gamma-aminobutyric acid(B) receptor-mediated analgesia in the mouse tail-flick assay. Neurosci. Lett. 292 (2000) 83-86
6. Du L.N., Wu G.C., and Cao X.D. Modulation of orphanin FQ or electroacupuncture (EA) on immune function of traumatic rats. Acupunct. Electro-Ther. Res. 23 (1998) 1-8
7. Goldstein A., Tachibana S., Lowney L.I., Hunkapiller M., and Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 6666-6670
8. Grisel J.E., Mogil J.S., Belknap J.K., and Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. NeuroReport 7 (1996) 2125-2129
9. Handler C.M., Piliero T., Geller E.B., and Adler M.W. Effect of ambient temperature on the ability of mu-, kappa-, and delta-selective opioid agonists to modulate thermoregulatory mechanisms in the rat. J. Pharmacol. Exp. Ther. 268 (1994) 847-855
10. Heinricher M.M. Orphanin FQ/nociceptin: from neural circuitry to behavior. Life Sci. 73 (2003) 813-822
11. Heinricher M.M. Nociceptin/orphanin FQ: pain, stress and neural circuits. Life Sci. 77 (2005) 3127-3132
12. Heinricher M.M., McGaraughty S., and Grandy D.K. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J. Neurophysiol. 78 (1997) 3351-3358
13. Jenck F., Moreau J.L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma Jr. F.J., Nothacker H.P., and Civelli O. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 14854-14858
14. King M., Chang A., and Pasternak G.W. Functional blockade of opioid analgesia by orphanin FQ/nociceptin. Biochem. Pharmacol. 55 (1998) 1537-1540
15. Lutfy K., and Maidment N.T. Blockade of mu-opioid receptors reveals the hyperalgesic effect of orphanin FQ/nociceptin in the rat hot plate test. Br. J. Pharmacol. 131 (2000) 1684-1688
16. Lutfy K., Sharza S.A., and Maidment N.T. Tolerance develops to the inhibitory effect of orphanin FQ on morphine-induced antinociception in the rat. NeuroReport 10 (1999) 103-106
17. Meis S. Nociceptin/orphanin FQ: actions within the brain. Neuroscientist 9 (2003) 158-168
18. Meunier J.-C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.-L., Gulllemot J.-C., Ferrara P., monsarrat B., Mazargull H., Vassart G., Parmentler M., and Costentin J. Isolation and structure of the endogenous agonists of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
19. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., and Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience 75 (1996) 333-337
20. Mogil J.S., Grisel J.E., Zhang G., Belknap J.K., and Grandy D.K. Functional antagonism of μ-, δ-, and κ-opioid antinociception by orphanin FQ. Neurosci. Lett. 214 (1996) 131-134
21. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53 (2001) 381-415
22. Moran T.D., Abdulla F.A., and Smith P.A. Cellular neurophysiological actions of nociceptin/orphanin FQ. Peptides 21 (2000) 969-976
23. Morgan M.M., Grisel J.E., Robbins C.S., and Grandy D.K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. NeuroReport 8 (1997) 3431-3434
24. Mosberg H.I., Hurst R., Hruby V.J., Gee K., Yamamura H.I., Galligan J.J., and Burks T.F. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 5871-5874
25. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Akil H., and Watson Jr. S.J. Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J. Comp. Neurol. 412 (1999) 563-605
26. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., and Watson Jr. S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406 (1999) 03-47
27. Neubert M.J., Kincaid W., and Heinricher M.M. Nociceptive facilitating neurons in the rostral ventromedial medulla. Pain 110 (2004) 158-165
28. Pellegrino L.J., and Cushman A.J. In: Elliott R.M., Lindzey G., and MacCorquodale K. (Eds). A Stereotaxic Atlas of the Rat Brain (1967), Appleton-Century-Crofts, New York
29. Pizziketti R.J., Pressman N.S., Geller E.B., Cowan A., and Adler M.W. Rat cold water tail-flick: a novel analgesic test that distinguishes opioid agonists from mixed agonist-antagonists. Eur. J. Pharmacol. 119 (1985) 23-29
30. Reinscheid R.K., Nothacker H.-P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma Jr. F.J., and Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270 (1995) 792-794
31. Sandrini M., Vitale G., Pini L.A., Lopetuso G., Romualdi P., and Candeletti S. Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test. Eur. J. Pharmacol. 507 (2005) 43-48
32. Shane R., Lazar D.A., Rossi G.C., Pasternak G.W., and Bodnar R.J. Analgesia elicited by OFQ/nociceptin and its fragments from the amygdala in rats. Brain Res. 907 (2001) 109-116
33. Suaudeau C., Florin S., Meunier J.C., and Costentin J. Nociceptin-induced apparent hyperalgesia in mice as a result of the prevention of opioid autoanalgesic mechanisms triggered by the stress of an intracerebroventricular injection. Fundam. Clin. Pharmacol. 12 (1998) 420-425
34. Tian J.-H., Zhang W., Fang Y., Xu W., Grandy D.K., and Han J.-S. Endogenous orphanin FQ: evidence for a role in the modulation of electroacupuncture analgesia and the development of tolerance to analgesia produced by morphine and electroacupuncture. Br. J. Pharmacol. 124 (1998) 21-26
35. Vanderah T.W., Raffa R.B., Lashbrook J., Burritt A., Hruby V.V., and Porreca F. Orphanin-FQ/nociceptin: lack of antinociceptive, hyperalgesic or allodynic effects in acute thermal or mechanical tests following intracerebroventricular or intrathecal administration to mice or rats. Eur. J. Pain 2 (1998) 67-280
36. Wadenberg M.L. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. CNS Drug Rev. 9 (2003) 187-198 (Review)
37. Wang H., Zhu C.B., Cao X.D., and Wu G.C. Effect of orphanin FQ on acupuncture analgesia and noxious stimulation in the periaqueductal gray. Sheng Li Xue Bao 50 (1998) 263-267 (Chinese)
38. Xu X.J., Hao J.X., and Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. NeuroReport 7 (1996) 2092-2094
39. Yuan L., Han Z., Chang J.-K., and Han J.-S. Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats. Brain Res. 826 (1999) 330-334
40. Zhang X.L., Zhu C.B., Xu S.F., Cao X.D., Wu G.C., Li M.Y., Cui D.F., and Chi C.W. Effect of intrathecal or intracerebroventricular administrition of OFQ on pain threshold and acupuncture analgesia in rats. Sheng Li Xue Bao 49 (1997) 575-580 (Chinese)
41. Zhu C.B., Xu S.F., Cao X.D., Wu G.C., Zhang X.L., Li M.Y., Cui D.F., and Chi C.W. Antagonistic action of orphanin FQ on acupuncture analgesia in rat brain. Acupunct. Electro-Ther. Res. 21 (1996) 199-205
42. Zhu C.-B., Cao X.-D., Xu S.-F., and Wu G.-C. Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci. Lett. 235 (1997) 37-40